Anaconda Biomed S.L.
PrivateLast Round
VC Round
Jan 9, 2025
Total Funding Raised
$50.56M
Company Overview
Anaconda Biomed S.L. is a medical technology company that develops next-generation thrombectomy systems for the treatment of ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaconda Biomed S.L. Comparables
Compare Anaconda Biomed S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perfuze | 93% | |
| NeuroVasc Technologies | 91% | |
| MIVI Neuroscience | 91% | |
Anaconda Biomed S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 9, 2025 | ||||
| Debt | Oct 6, 2021 | ||||
| Series B | Dec 4, 2019 | ||||
| Grant | Aug 9, 2018 | ||||
| Series A | May 22, 2017 |
Anaconda Biomed S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Series B |
| Omega Funds | Series B, Series A |
| Ysios Capital | Series B, VC Round, Series A |
| Innogest Capital | Series B, Series A |
| EIT Health | Grant |
| European Investment Bank Group | Debt |
| Sabadell Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2025
Dr. Charles 'Chuck' Carignan appointed Chairman of the board.
- May 29, 2025
CEO Trent Reutiman presented at the LSI USA '25 Emerging Medtech Summit.
Anaconda Biomed S.L. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anaconda Biomed S.L.'s valuation, stock price, and market status.